Dupont Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,026
| Closed | -$641K | – | 270 |
|
|
2023
Q2 | $641K | Sell |
10,026
-6,194
| -38% | -$415K | 0.03% | 235 |
|
|
2023
Q1 | $1.12M | Sell |
16,220
-36,066
| -69% | -$2.54M | 0.05% | 175 |
|
|
2022
Q4 | $3.76M | Sell |
52,286
-5,507
| -10% | -$415K | 0.18% | 78 |
|
|
2022
Q3 | $4.11M | Sell |
57,793
-9,757
| -14% | -$708K | 0.24% | 56 |
|
|
2022
Q2 | $5.2M | Sell |
67,550
-9,833
| -13% | -$749K | 0.24% | 61 |
|
|
2022
Q1 | $5.65M | Sell |
77,383
-23,410
| -23% | -$1.57M | 0.23% | 66 |
|
|
2021
Q4 | $6.28M | Sell |
100,793
-20,666
| -17% | -$1.21M | 0.22% | 80 |
|
|
2021
Q3 | $7.19M | Sell |
121,459
-18,715
| -13% | -$1.23M | 0.23% | 75 |
|
|
2021
Q2 | $9.37M | Sell |
140,174
-4,662
| -3% | -$304K | 0.22% | 79 |
|
|
2021
Q1 | $9.14M | Buy |
144,836
+17,874
| +14% | +$1.11M | 0.22% | 76 |
|
|
2020
Q4 | $7.88M | Sell |
126,962
-10,127
| -7% | -$623K | 0.17% | 100 |
|
|
2020
Q3 | $8.27M | Buy |
137,089
+19,504
| +17% | +$1.17M | 0.18% | 103 |
|
|
2020
Q2 | $6.91M | Buy |
117,585
+50,358
| +75% | +$3.01M | 0.15% | 121 |
|
|
2020
Q1 | $3.75M | Sell |
67,227
-33,155
| -33% | -$2.03M | 0.09% | 165 |
|
|
2019
Q4 | $6.44M | Buy |
100,382
+29,647
| +42% | +$1.7M | 0.14% | 118 |
|
|
2019
Q3 | $3.59M | Sell |
70,735
-48,268
| -41% | -$2.27M | 0.08% | 210 |
|
|
2019
Q2 | $5.4M | Sell |
119,003
-4,805
| -4% | -$224K | 0.12% | 153 |
|
|
2019
Q1 | $5.91M | Buy |
123,808
+14,841
| +14% | +$739K | 0.13% | 138 |
|
|
2018
Q4 | $5.66M | Sell |
108,967
-49,217
| -31% | -$2.64M | 0.14% | 134 |
|
|
2018
Q3 | $9.82M | Sell |
158,184
-6,182
| -4% | -$367K | 0.22% | 80 |
|
|
2018
Q2 | $9.1M | Buy |
164,366
+19,559
| +14% | +$1.06M | 0.22% | 85 |
|
|
2018
Q1 | $9.16M | Buy |
144,807
+82,184
| +131% | +$5.29M | 0.22% | 83 |
|
|
2017
Q4 | $3.84M | Buy |
62,623
+17,176
| +38% | +$1.07M | 0.09% | 228 |
|
|
2017
Q3 | $2.9M | Buy |
45,447
+5,802
| +15% | +$339K | 0.07% | 271 |
|
|
2017
Q2 | $2.21M | Buy |
+39,645
| New | +$2.16M | 0.05% | 336 |
|
|
2014
Q1 | – | Sell |
-30,566
| Closed | -$1.63M | – | 627 |
|
|
2013
Q4 | $1.63M | Sell |
30,566
-86,491
| -74% | -$4.41M | 0.03% | 408 |
|
|
2013
Q3 | $5.42M | Sell |
117,057
-15,268
| -12% | -$670K | 0.1% | 184 |
|
|
2013
Q2 | $5.91M | Buy |
+132,325
| New | +$5.74M | 0.11% | 176 |
|
Other funds holding BMY
Dupont Capital Management's BMY Position: Q3 2023 in Review
Dupont Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 10,026 shares — an estimated $641K sold.
Dupont Capital Management first reported a position in BMY in Q2 2013 and held it in 28 quarters. The position peaked at $9.82M in Q3 2018. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- Dupont Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
- Dupont Capital Management sold 10,026 Bristol-Myers Squibb shares in Q3 2023, an estimated $641K.
- Dupont Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 28 quarters.
- Dupont Capital Management's Bristol-Myers Squibb position peaked at $9.82M in Q3 2018.
- 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on Dupont Capital Management's 13F filing for Q3 2023, filed 27 Oct 2023.